Skip to main content
. 2020 Feb 18;8(2):35. doi: 10.3390/biomedicines8020035

Scheme 1.

Scheme 1

The in vitro anticancer properties of 5-(carbamoylmethylene)-oxazolidin-2-ones (OA-OI).